绿叶制药(02186.HK) 公布,集团多款创新产品成功纳入《国家基本医疗保险、工伤保险和生育保险药品目录(2024年)》。其中包括若欣林®获首次纳入、百拓维®新增纳入乳腺癌适应症,以及和力扑素®纳入常规目录。新版国家医保药品目录将于2025年1月1日起正式实施。(vc/w)
(港股报价延迟最少十五分钟。沽空资料截至 2024-11-27 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.